1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Crystalloids 1.2.3 Colloids 1.2.4 Others 1.3 Market by Application 1.3.1 Global Sterile Intravenous (IV) Solution Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Medications 1.3.3 NutritionNutrition 1.3.4 Blood-based Products 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Sterile Intravenous (IV) Solution Market Perspective (2016-2027) 2.2 Sterile Intravenous (IV) Solution Growth Trends by Regions 2.2.1 Sterile Intravenous (IV) Solution Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Sterile Intravenous (IV) Solution Historic Market Share by Regions (2016-2021) 2.2.3 Sterile Intravenous (IV) Solution Forecasted Market Size by Regions (2022-2027) 2.3 Sterile Intravenous (IV) Solution Industry Dynamic 2.3.1 Sterile Intravenous (IV) Solution Market Trends 2.3.2 Sterile Intravenous (IV) Solution Market Drivers 2.3.3 Sterile Intravenous (IV) Solution Market Challenges 2.3.4 Sterile Intravenous (IV) Solution Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Sterile Intravenous (IV) Solution Players by Revenue 3.1.1 Global Top Sterile Intravenous (IV) Solution Players by Revenue (2016-2021) 3.1.2 Global Sterile Intravenous (IV) Solution Revenue Market Share by Players (2016-2021) 3.2 Global Sterile Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Sterile Intravenous (IV) Solution Revenue 3.4 Global Sterile Intravenous (IV) Solution Market Concentration Ratio 3.4.1 Global Sterile Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Sterile Intravenous (IV) Solution Revenue in 2020 3.5 Sterile Intravenous (IV) Solution Key Players Head office and Area Served 3.6 Key Players Sterile Intravenous (IV) Solution Product Solution and Service 3.7 Date of Enter into Sterile Intravenous (IV) Solution Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Sterile Intravenous (IV) Solution Breakdown Data by Type 4.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Type (2016-2021) 4.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2022-2027) 5 Sterile Intravenous (IV) Solution Breakdown Data by Application 5.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Application (2016-2021) 5.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Sterile Intravenous (IV) Solution Market Size (2016-2027) 6.2 North America Sterile Intravenous (IV) Solution Market Size by Type 6.2.1 North America Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) 6.2.2 North America Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) 6.2.3 North America Sterile Intravenous (IV) Solution Market Size by Type (2016-2027) 6.3 North America Sterile Intravenous (IV) Solution Market Size by Application 6.3.1 North America Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) 6.3.2 North America Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) 6.3.3 North America Sterile Intravenous (IV) Solution Market Size by Application (2016-2027) 6.4 North America Sterile Intravenous (IV) Solution Market Size by Country 6.4.1 North America Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) 6.4.2 North America Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Sterile Intravenous (IV) Solution Market Size (2016-2027) 7.2 Europe Sterile Intravenous (IV) Solution Market Size by Type 7.2.1 Europe Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) 7.2.2 Europe Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) 7.2.3 Europe Sterile Intravenous (IV) Solution Market Size by Type (2016-2027) 7.3 Europe Sterile Intravenous (IV) Solution Market Size by Application 7.3.1 Europe Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) 7.3.2 Europe Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) 7.3.3 Europe Sterile Intravenous (IV) Solution Market Size by Application (2016-2027) 7.4 Europe Sterile Intravenous (IV) Solution Market Size by Country 7.4.1 Europe Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) 7.4.2 Europe Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size (2016-2027) 8.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type 8.2.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2016-2027) 8.3 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application 8.3.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2016-2027) 8.4 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region 8.4.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Sterile Intravenous (IV) Solution Market Size (2016-2027) 9.2 Latin America Sterile Intravenous (IV) Solution Market Size by Type 9.2.1 Latin America Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) 9.2.2 Latin America Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) 9.2.3 Latin America Sterile Intravenous (IV) Solution Market Size by Type (2016-2027) 9.3 Latin America Sterile Intravenous (IV) Solution Market Size by Application 9.3.1 Latin America Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) 9.3.2 Latin America Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) 9.3.3 Latin America Sterile Intravenous (IV) Solution Market Size by Application (2016-2027) 9.4 Latin America Sterile Intravenous (IV) Solution Market Size by Country 9.4.1 Latin America Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) 9.4.2 Latin America Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size (2016-2027) 10.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type 10.2.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2016-2027) 10.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application 10.3.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2016-2027) 10.4 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country 10.4.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 B. Braun Medical Inc. 11.1.1 B. Braun Medical Inc. Company Details 11.1.2 B. Braun Medical Inc. Business Overview 11.1.3 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Introduction 11.1.4 B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.1.5 B. Braun Medical Inc. Recent Development 11.2 Technoflex 11.2.1 Technoflex Company Details 11.2.2 Technoflex Business Overview 11.2.3 Technoflex Sterile Intravenous (IV) Solution Introduction 11.2.4 Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.2.5 Technoflex Recent Development 11.3 Baxter International 11.3.1 Baxter International Company Details 11.3.2 Baxter International Business Overview 11.3.3 Baxter International Sterile Intravenous (IV) Solution Introduction 11.3.4 Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.3.5 Baxter International Recent Development 11.4 ICU Medical, Inc 11.4.1 ICU Medical, Inc Company Details 11.4.2 ICU Medical, Inc Business Overview 11.4.3 ICU Medical, Inc Sterile Intravenous (IV) Solution Introduction 11.4.4 ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.4.5 ICU Medical, Inc Recent Development 11.5 Mckesson 11.5.1 Mckesson Company Details 11.5.2 Mckesson Business Overview 11.5.3 Mckesson Sterile Intravenous (IV) Solution Introduction 11.5.4 Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.5.5 Mckesson Recent Development 11.6 Amsino 11.6.1 Amsino Company Details 11.6.2 Amsino Business Overview 11.6.3 Amsino Sterile Intravenous (IV) Solution Introduction 11.6.4 Amsino Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.6.5 Amsino Recent Development 11.7 Wallcur 11.7.1 Wallcur Company Details 11.7.2 Wallcur Business Overview 11.7.3 Wallcur Sterile Intravenous (IV) Solution Introduction 11.7.4 Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.7.5 Wallcur Recent Development 11.8 Hebei Guangren Pharmaceutical Technology 11.8.1 Hebei Guangren Pharmaceutical Technology Company Details 11.8.2 Hebei Guangren Pharmaceutical Technology Business Overview 11.8.3 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Introduction 11.8.4 Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.8.5 Hebei Guangren Pharmaceutical Technology Recent Development 11.9 Jiangsu Hengfengqiang Biotechnology 11.9.1 Jiangsu Hengfengqiang Biotechnology Company Details 11.9.2 Jiangsu Hengfengqiang Biotechnology Business Overview 11.9.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction 11.9.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.9.5 Jiangsu Hengfengqiang Biotechnology Recent Development 11.10 Hospira 11.10.1 Hospira Company Details 11.10.2 Hospira Business Overview 11.10.3 Hospira Sterile Intravenous (IV) Solution Introduction 11.10.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.10.5 Hospira Recent Development 11.11 Jiangsu Hengfengqiang Biotechnology 11.11.1 Jiangsu Hengfengqiang Biotechnology Company Details 11.11.2 Jiangsu Hengfengqiang Biotechnology Business Overview 11.11.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction 11.11.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.11.5 Jiangsu Hengfengqiang Biotechnology Recent Development 11.12 Hospira 11.12.1 Hospira Company Details 11.12.2 Hospira Business Overview 11.12.3 Hospira Sterile Intravenous (IV) Solution Introduction 11.12.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.12.5 Hospira Recent Development 11.13 Xi'an Libang Alliance Enterprise Management 11.13.1 Xi'an Libang Alliance Enterprise Management Company Details 11.13.2 Xi'an Libang Alliance Enterprise Management Business Overview 11.13.3 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Introduction 11.13.4 Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.13.5 Xi'an Libang Alliance Enterprise Management Recent Development 11.14 Livzon Group 11.14.1 Livzon Group Company Details 11.14.2 Livzon Group Business Overview 11.14.3 Livzon Group Sterile Intravenous (IV) Solution Introduction 11.14.4 Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) 11.14.5 Livzon Group Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Crystalloids Table 3. Key Players of Colloids Table 4. Key Players of Others Table 5. Global Sterile Intravenous (IV) Solution Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Sterile Intravenous (IV) Solution Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Sterile Intravenous (IV) Solution Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Sterile Intravenous (IV) Solution Market Share by Regions (2016-2021) Table 9. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Sterile Intravenous (IV) Solution Market Share by Regions (2022-2027) Table 11. Sterile Intravenous (IV) Solution Market Trends Table 12. Sterile Intravenous (IV) Solution Market Drivers Table 13. Sterile Intravenous (IV) Solution Market Challenges Table 14. Sterile Intravenous (IV) Solution Market Restraints Table 15. Global Sterile Intravenous (IV) Solution Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Sterile Intravenous (IV) Solution Market Share by Players (2016-2021) Table 17. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sterile Intravenous (IV) Solution as of 2020) Table 18. Ranking of Global Top Sterile Intravenous (IV) Solution Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Sterile Intravenous (IV) Solution Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Sterile Intravenous (IV) Solution Product Solution and Service Table 22. Date of Enter into Sterile Intravenous (IV) Solution Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million) Table 25. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2016-2021) Table 26. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Sterile Intravenous (IV) Solution Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Sterile Intravenous (IV) Solution Revenue Market Share by Application (2016-2021) Table 30. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Sterile Intravenous (IV) Solution Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million) Table 33. North America Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million) Table 35. North America Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2022-2027) & (US$ Million) Table 62. B. Braun Medical Inc. Company Details Table 63. B. Braun Medical Inc. Business Overview Table 64. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product Table 65. B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 66. B. Braun Medical Inc. Recent Development Table 67. Technoflex Company Details Table 68. Technoflex Business Overview Table 69. Technoflex Sterile Intravenous (IV) Solution Product Table 70. Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 71. Technoflex Recent Development Table 72. Baxter International Company Details Table 73. Baxter International Business Overview Table 74. Baxter International Sterile Intravenous (IV) Solution Product Table 75. Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 76. Baxter International Recent Development Table 77. ICU Medical, Inc Company Details Table 78. ICU Medical, Inc Business Overview Table 79. ICU Medical, Inc Sterile Intravenous (IV) Solution Product Table 80. ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 81. ICU Medical, Inc Recent Development Table 82. Mckesson Company Details Table 83. Mckesson Business Overview Table 84. Mckesson Sterile Intravenous (IV) Solution Product Table 85. Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 86. Mckesson Recent Development Table 87. Amsino Company Details Table 88. Amsino Business Overview Table 89. Amsino Sterile Intravenous (IV) Solution Product Table 90. Amsino Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 91. Amsino Recent Development Table 92. Wallcur Company Details Table 93. Wallcur Business Overview Table 94. Wallcur Sterile Intravenous (IV) Solution Product Table 95. Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 96. Wallcur Recent Development Table 97. Hebei Guangren Pharmaceutical Technology Company Details Table 98. Hebei Guangren Pharmaceutical Technology Business Overview Table 99. Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 100. Hebei Guangren Pharmaceutical Technology Recent Development Table 101. Jiangsu Hengfengqiang Biotechnology Company Details Table 102. Jiangsu Hengfengqiang Biotechnology Business Overview Table 103. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Table 104. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 105. Jiangsu Hengfengqiang Biotechnology Recent Development Table 106. Hospira Company Details Table 107. Hospira Business Overview Table 108. Hospira Sterile Intravenous (IV) Solution Product Table 109. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 110. Hospira Recent Development Table 111. Jiangsu Hengfengqiang Biotechnology Company Details Table 112. Jiangsu Hengfengqiang Biotechnology Business Overview Table 113. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product Table 114. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 115. Jiangsu Hengfengqiang Biotechnology Recent Development Table 116. Hospira Company Details Table 117. Hospira Business Overview Table 118. Hospira Sterile Intravenous (IV) Solution Product Table 119. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 120. Hospira Recent Development Table 121. Xi'an Libang Alliance Enterprise Management Company Details Table 122. Xi'an Libang Alliance Enterprise Management Business Overview Table 123. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product Table 124. Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 125. Xi'an Libang Alliance Enterprise Management Recent Development Table 126. Livzon Group Company Details Table 127. Livzon Group Business Overview Table 128. Livzon Group Sterile Intravenous (IV) Solution Product Table 129. Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2016-2021) & (US$ Million) Table 130. Livzon Group Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Sterile Intravenous (IV) Solution Market Share by Type: 2020 VS 2027 Figure 2. Crystalloids Features Figure 3. Colloids Features Figure 4. Others Features Figure 5. Global Sterile Intravenous (IV) Solution Market Share by Application: 2020 VS 2027 Figure 6. Medications Case Studies Figure 7. NutritionNutrition Case Studies Figure 8. Blood-based Products Case Studies Figure 9. Others Case Studies Figure 10. Sterile Intravenous (IV) Solution Report Years Considered Figure 11. Global Sterile Intravenous (IV) Solution Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Sterile Intravenous (IV) Solution Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Sterile Intravenous (IV) Solution Market Share by Regions: 2020 VS 2027 Figure 14. Global Sterile Intravenous (IV) Solution Market Share by Regions (2022-2027) Figure 15. Global Sterile Intravenous (IV) Solution Market Share by Players in 2020 Figure 16. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sterile Intravenous (IV) Solution as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Sterile Intravenous (IV) Solution Revenue in 2020 Figure 18. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2016-2021) Figure 19. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2022-2027) Figure 20. North America Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Sterile Intravenous (IV) Solution Market Share by Type (2016-2027) Figure 22. North America Sterile Intravenous (IV) Solution Market Share by Application (2016-2027) Figure 23. North America Sterile Intravenous (IV) Solution Market Share by Country (2016-2027) Figure 24. United States Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Sterile Intravenous (IV) Solution Market Share by Type (2016-2027) Figure 28. Europe Sterile Intravenous (IV) Solution Market Share by Application (2016-2027) Figure 29. Europe Sterile Intravenous (IV) Solution Market Share by Country (2016-2027) Figure 30. Germany Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Sterile Intravenous (IV) Solution Market Share by Type (2016-2027) Figure 38. Asia-Pacific Sterile Intravenous (IV) Solution Market Share by Application (2016-2027) Figure 39. Asia-Pacific Sterile Intravenous (IV) Solution Market Share by Region (2016-2027) Figure 40. China Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Sterile Intravenous (IV) Solution Market Share by Type (2016-2027) Figure 48. Latin America Sterile Intravenous (IV) Solution Market Share by Application (2016-2027) Figure 49. Latin America Sterile Intravenous (IV) Solution Market Share by Country (2016-2027) Figure 50. Mexico Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Sterile Intravenous (IV) Solution Market Share by Type (2016-2027) Figure 54. Middle East & Africa Sterile Intravenous (IV) Solution Market Share by Application (2016-2027) Figure 55. Middle East & Africa Sterile Intravenous (IV) Solution Market Share by Country (2016-2027) Figure 56. Turkey Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Sterile Intravenous (IV) Solution Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. B. Braun Medical Inc. Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 60. Technoflex Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 61. Baxter International Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 62. ICU Medical, Inc Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 63. Mckesson Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 64. Amsino Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 65. Wallcur Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 66. Hebei Guangren Pharmaceutical Technology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 67. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 68. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 69. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 70. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 71. Xi'an Libang Alliance Enterprise Management Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 72. Livzon Group Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

B. Braun Medical Inc. Technoflex Baxter International ICU Medical, Inc Mckesson Amsino Wallcur Hebei Guangren Pharmaceutical Technology Jiangsu Hengfengqiang Biotechnology Hospira Jiangsu Hengfengqiang Biotechnology Hospira Xi'an Libang Alliance Enterprise Management Livzon Group